Target intelligence / Profile preview

G protein signaling modulator 3 (GPSM3)

Target
GPSM3
Molecular classification
Other (GoLoco motif protein), Signal transduction modulator
01

Overview

G protein signaling modulator 3 (GPSM3) is a cytoplasmic protein highly expressed in leukocytes that regulates heterotrimeric G protein signaling downstream of G protein-coupled receptors (GPCRs). It contains GoLoco motifs enabling it to interact with Gα_i and Gβ subunits, functioning as a guanine nucleotide dissociation inhibitor (GDI) and thus modulating GPCR signal strength and duration. GPSM3 plays a critical role in immune cell migration and inflammation and is implicated as both a biomarker and a putative therapeutic target for autoimmune and inflammatory diseases, especially rheumatoid arthritis[1][2][3][4][5][7]. Genome-wide association studies have linked GPSM3 polymorphisms to autoimmune conditions, further supporting its relevance in disease biology[1][3]. No known direct small molecule or biologic drug interactions have yet been reported for GPSM3 as of current knowledge[2][3].

Other names
AGS4C6orf9G18NG1G18.1aG18.1bG18.2Activator of G-protein signaling 4Protein G18
02

Mechanism of action

Inhibition of G protein (Gα_i) nucleotide exchange (GDP dissociation inhibitor activity). Modulation of GPCR signaling by interacting with G protein subunits (Gα_i, Gβ).

03

Biological functions

Signal transductionPositive regulation of inflammatory responseRegulation of cytokine productionRegulation of leukocyte chemotaxisCell migrationMonocyte function
04

Disease associations

InflammationAutoimmune disease (e.g., rheumatoid arthritis)Cancer (weak evidence, e.g., prostate leiomyosarcoma, anal carcinoma in situ)
05

Safety considerations

Potential immunological effects due to modulation of immune cell migration and survivalAltered susceptibility to inflammatory and autoimmune diseases
06

Biomarkers

Genetic variants (SNPs) in GPSM3 associated with autoimmune and inflammatory diseases

Beyond the preview

Go deeper on G protein signaling modulator 3 (GPSM3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein signaling modulator 3 (GPSM3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call